-
Ministry of Agriculture and Rural Affairs announced 100 national planting industry "three products and one standard" bases
Time of Update: 2022-01-09
This year, the Ministry of Agriculture and Rural Affairs organized the promotion of "three products and one standard" in agricultural production, focusing on variety cultivation, quality improvement, brand building and standardized production, and promoting green agricultural development in higher and deeper fields .
-
2022 China International Home Care Exhibition for the Disabled / Nursing Products Exhibition
Time of Update: 2022-01-07
We invite you to discuss the new direction of the global welfare industry: In line with the current good development trend of China's rehabilitation industry, China Shandong International Welfare Exhibition | Rehabilitation Equipment and Disabled Products Exhibition will keep pace with the market and seize the booming business opportunities.
-
The price of Jinyingzi breaks 20 yuan, can the upward trend continue?
Time of Update: 2022-01-02
At that time, the low-price operation for several consecutive years reduced the farmers' picking efforts, resulting in a decline in the output of new golden cherry seeds in 2014.
-
Internet advertising supervision welcomes new changes: Live broadcast of drug and health food advertisements is not allowed
Time of Update: 2022-01-02
On November 26, the State Administration for Market Regulation issued an announcement on its website stating that in accordance with the “Advertising Law of the People’s Republic of China” and other
-
What is the collection of raw material drug production and supply information?
Time of Update: 2022-01-02
This time, the State Food and Drug Administration issued a notice to collect information on the production and supply of raw materials, preparing the way for the future to dynamically adjust the GMP inspection and supervision plan according to the production situation of the enterprise .
-
Significant changes have taken place in the market structure of traditional Chinese medicinal materials
Time of Update: 2022-01-02
Speaking of China's "Four Major Medicine Capitals", Bozhou in Anhui, Anguo in Hebei, Zhangshu in Jiangxi, and Yuzhou in Henan are the areas with the highest recognition in history. These areas are b
-
Sanming Alliance will further expand and gradually promote the alliance procurement of all categories of medicines, consumables, and Chinese herbal medicines!
Time of Update: 2022-01-02
It is understood that the Sanming Alliance City Medical Institutions will take the lead in carrying out cross-regional joint procurement of medicines and equipment other than the national and provincial drug purchases .
-
Chengdu Beite reviews the cephalosporin injection with a peak value of 900 million
Time of Update: 2022-01-02
On November 26, the NMPA official website released the latest drug approval information, and Chengdu Better Pharmaceutical's cefepime hydrochloride for injection passed the consistency evaluation .
Table 2: The situation of cephalosporin products reviewed by Chengdu Better Pharmaceutical Source: Meinenet MED2.
-
2 billion large varieties of parecoxib sodium for injection!
Time of Update: 2022-01-02
On November 29, Buchang Pharmaceuticals announced that its wholly-owned subsidiary Shandong Danhong's parecoxib sodium for injection was approved for listing .
Parecoxib sodium for injection is a selective COX-2 inhibitor, and its terminal sales in China's public medical institutions will exceed 2 billion yuan in 2020 .
-
With many expectations on the establishment of the National Anti-Monopoly Bureau, the public opinion is highly appraised
Time of Update: 2022-01-02
Overview of the incident The Ministry of Human Resources and Social Security website announced on November 15 that the State Council appointed Gan Lin as the director of the National Anti-Monopoly Bureau, which aroused public attention to the new agency "National Anti-Monopoly Bureau .
-
Prohibition of selling drugs first and supplementing prescriptions Internet medical services will bid farewell to barbaric growth
Time of Update: 2022-01-02
Lu Qingjun, director of the Office of the National Center for Telemedicine and Internet Medicine, once pointed out that China’s Internet medical industry policies are not implemented in place; some models have unreasonable service processes, and diagnosis and treatment standards are not sound; many institutions have poor doctor access supervision and process supervision, and online diagnosis and treatment.
-
Viewing the patent layout strategy of combination therapy from the cooperation between Hengrui and Cornerstone
Time of Update: 2022-01-02
Therefore, based on the current information disclosed by CStone Pharmaceuticals, the combination of CS1002 and CS1003 may be difficult for China to obtain exclusive patent rights, but there is still room for Europe and the United States .
-
TOP20 retail products of Chinese patent medicinal plasters released, 4 products rose by more than 30%
Time of Update: 2022-01-02
Among them, 11 are exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Wuxi Pharmaceutical, Yabao Pharmaceutical, Henan Lingrui Pharmaceutical and other enterprises, and Xiaotong Plaster is stable "Yi Ge" throne, sales reached a new high; in terms of growth rate, 4 products including waist and kidney ointment and red medicine plaster all rose by more than 30% .
-
Bio-similar drugs accelerate overtaking, Qilu breaks the game, Biotech loses weight
Time of Update: 2022-01-02
In the first half of this year, among the top 10 Western medicines sold in public hospitals in key provinces and cities, Qilu’s bevacizumab has the fastest growth rate, and its market share has surpassed The original research drug, plus more than 20 companies such as Fuhong Henlius and Corning Jerry are still racing in this field, and the competition is extremely fierce .
-
"Special medicine" routines need to be cautious when seeking medical advice on the Internet
Time of Update: 2021-12-31
In a large-scale telecommunications network fraud reported by the police in Nantong City, Jiangsu Province recently, a criminal group disguised as a legitimate company, used methods such as fictitious medical experts and exaggerating the efficacy of drugs, causing more than 100,000 people across the country to fall into the scam, with a total amount of 3 Billion yuan .
-
The average price of 67 new drugs added by the National Medical Insurance Drugs has been reduced by 61.71%!
Time of Update: 2021-12-31
Huang Huabo, director of the Fund Supervision Department of the National Medical Security Administration, said that the scope of the 2021 National Medical Insurance Drug List adjustment includes drugs newly marketed or modified in the label in the past five years, national essential drugs, and drugs used for the treatment of new coronary pneumonia .
-
Refuse to import!
Time of Update: 2021-12-31
According to the China Government Procurement Network, the Health Bureau of Nanxiong City, Guangdong Province issued a tender announcement with a total budget of nearly 40 million to purchase a batch of medical equipment for primary medical institutions in Nanxiong City .
-
Step impact best-selling painkillers!
Time of Update: 2021-12-31
com, the sales of pregabalin capsules in physical pharmacies in Chinese cities will exceed the 100 million mark in 2020, and it is expected to reach a new high in 2021 .
-
The Medical Insurance Bureau has issued a document that there are five types of situations that can initiate unannounced inspections!
Time of Update: 2021-12-31
. Article 13 The medical security administrative department of the inspected province (city) shall cooperate with the unannounced inspections, provide timely, true, complete and accurate policy documents, data information and other relevant materials, and send administrative law enforcement personnel to participate in the on-site inspections .
-
The results of the national selection of insulin are released!
Time of Update: 2021-12-31
2) The basic purchase volume of some selected varieties has not been announced and cannot be included in the calculation scope of 15 varieties A drop of over 50% According to the statistics of the medical cloud studio, the average drop of the selected varieties of insulin in this centralized procurement relative to the limit price was 48.
